BEADBLOCK USA
Device
Biocompatibles UK Ltd
Total Payments
$216,217
Transactions
5
Doctors
2
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $3,546 | 2 | 2 |
| 2018 | $94,754 | 1 | 0 |
| 2017 | $117,916 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $212,671 | 3 | 98.4% |
| Consulting Fee | $3,546 | 2 | 1.6% |
Payments by Type
Research
$212,671
3 transactions
General
$3,546
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Prostatic Artery Embolization PAE for Treatment for Signs & Symptoms of Benign Prostatic Hyperplasia BPH | Biocompatibles UK Ltd | $212,671 | 0 |
Ad
Manufacturing Companies
- Biocompatibles UK Ltd $212,671
- Boston Scientific Corporation $3,546
Product Information
- Type Device
- Total Payments $216,217
- Total Doctors 2
- Transactions 5
About BEADBLOCK USA
BEADBLOCK USA is a device associated with $216,217 in payments to 2 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Biocompatibles UK Ltd.
Payment data is available from 2017 to 2020. In 2020, $3,546 was paid across 2 transactions to 2 doctors.
The most common payment nature for BEADBLOCK USA is "Unspecified" ($212,671, 98.4% of total).
BEADBLOCK USA is associated with 1 research study, including "Prostatic Artery Embolization PAE for Treatment for Signs & Symptoms of Benign Prostatic Hyperplasia BPH" ($212,671).